{"id":32,"date":"2026-02-02T14:51:01","date_gmt":"2026-02-02T14:51:01","guid":{"rendered":"https:\/\/admarebio.com\/?page_id=32"},"modified":"2026-03-24T14:48:25","modified_gmt":"2026-03-24T14:48:25","slug":"news-insights","status":"publish","type":"page","link":"https:\/\/admarebio.com\/en\/news-events\/news-insights\/","title":{"rendered":"News &#038; Insights"},"content":{"rendered":"\n<div class=\"wp-block-cover alignfull is-style-bg-hex-pattern\" style=\"padding-top:var(--wp--preset--spacing--60);padding-right:var(--wp--preset--spacing--40);padding-bottom:var(--wp--preset--spacing--60);padding-left:var(--wp--preset--spacing--40);min-height:527px;aspect-ratio:unset;\"><img loading=\"lazy\" decoding=\"async\" width=\"2561\" height=\"1708\" class=\"wp-block-cover__image-background wp-image-949 size-full\" alt=\"\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/03\/Homepage-Gradient-flip.png\" data-object-fit=\"cover\" srcset=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/03\/Homepage-Gradient-flip.png 2561w, https:\/\/admarebio.com\/wp-content\/uploads\/2026\/03\/Homepage-Gradient-flip-1536x1024.png 1536w, https:\/\/admarebio.com\/wp-content\/uploads\/2026\/03\/Homepage-Gradient-flip-2048x1366.png 2048w\" sizes=\"auto, (max-width: 2561px) 100vw, 2561px\" \/><span aria-hidden=\"true\" class=\"wp-block-cover__background has-admare-blue-background-color has-background-dim-30 has-background-dim\"><\/span><div class=\"wp-block-cover__inner-container is-layout-flow wp-block-cover-is-layout-flow\">\n<div class=\"wp-block-group alignfull is-content-justification-left is-layout-constrained wp-container-core-group-is-layout-806bb2a1 wp-block-group-is-layout-constrained\">\n<h1 class=\"wp-block-heading alignwide has-h-2-font-size\" style=\"margin-bottom:0\">News &amp; insights<\/h1>\n<\/div>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group alignfull is-layout-constrained wp-block-group-is-layout-constrained\"><div class=\"is-layout-flow wp-block-group filter-archive alignfull  post\">\n\t<div class=\"is-layout-flow wp-block-group filters alignfull has-white-background\" style=\" padding-right:var(--wp--preset--spacing--40);padding-left:var(--wp--preset--spacing--40)\">\n\t\t<div class=\"wp-block-group alignwide\" style=\"padding-top: var(--wp--preset--spacing--30);padding-bottom: var(--wp--preset--spacing--30); max-width: var(--wp--style--global--wide-size); margin: 0 auto !important\">\n\t\t\t<form style=\"margin-bottom: 0;\" id=\"filter-form\" method=\"get\" class=\"is-layout-flex wp-block-columns\" data-post-type=\"post\" data-template-block-id=\"936\" data-empty-message=\"No matches found. Try another filter.\">\n\t\t\t\n\t\t\t\t\t\t\t<div class=\"filter-taxonomy wp-block-column button-container\" id=\"category\">\n\t\t\t\t\t\t\t\t\t\t<div class=\"wp-block-buttons alignwide is-layout-flex\" style=\"gap: clamp(0.5rem, 0.02rem + 2.04vw, 1rem);\">\n\t\t\t\t\t\t<div class=\"wp-block-button is-style-filter default\" data-taxonomy=\"category\">\n\t\t\t\t\t\t\t<button type=\"submit\" name=\"category\" value=\"\" class=\"wp-block-button__link active\">\n\t\t\t\t\t\t\t\tView All\t\t\t\t\t\t\t<\/button>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"wp-block-button is-style-filter\" data-term=\"admare-insights\" data-taxonomy=\"category\">\n\t\t\t\t\t\t\t\t<button type=\"submit\" name=\"category\" value=\"admare-insights\" class=\"wp-block-button__link \">\n\t\t\t\t\t\t\t\t\tadMare Insights\t\t\t\t\t\t\t\t<\/button>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"wp-block-button is-style-filter\" data-term=\"admare-news\" data-taxonomy=\"category\">\n\t\t\t\t\t\t\t\t<button type=\"submit\" name=\"category\" value=\"admare-news\" class=\"wp-block-button__link \">\n\t\t\t\t\t\t\t\t\tadMare News\t\t\t\t\t\t\t\t<\/button>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"wp-block-button is-style-filter\" data-term=\"portfolio-companies\" data-taxonomy=\"category\">\n\t\t\t\t\t\t\t\t<button type=\"submit\" name=\"category\" value=\"portfolio-companies\" class=\"wp-block-button__link \">\n\t\t\t\t\t\t\t\t\tPortfolio Companies\t\t\t\t\t\t\t\t<\/button>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\n\t\t\t<input type=\"hidden\" name=\"_orderby\" id=\"orderby\" value=\"post_date\">\n\t\t\t<input type=\"hidden\" name=\"_order\" id=\"order\" value=\"desc\">\n\t\t\t<input type=\"hidden\" name=\"_paged\" id=\"paged\" value=\"1\">\n\t\t\t<input type=\"hidden\" name=\"_per_page\" id=\"per_page\" value=\"60\">\n\t\t\t<input class=\"screen-reader-text\" type=\"submit\" value=\"Submit\">\n\t\t\t<\/form>\n\t\t<\/div>\n\t<\/div>\n\n\t<div class=\"is-layout-flow wp-block-query alignwide has-glacier-background-color\" style=\"padding-bottom: var(--wp--preset--spacing--70); padding-top: var(--wp--preset--spacing--60);padding-bottom: var(--wp--preset--spacing--60);padding-right:var(--wp--preset--spacing--40);padding-left:var(--wp--preset--spacing--40);margin-top: 0;\">\n\t\t<ul class=\"is-layout-flow is-flex-container columns-4 alignwide wp-block-post-template archive-items\" style=\"max-width: var(--wp--style--global--wide-size); margin: 0 auto !important\">\n\t\t\t<li class=\"wp-block-post post-2512 post type-post status-publish format-standard has-post-thumbnail hentry category-admare-insights\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/canada-has-the-science-does-it-have-the-strategy-to-be-a-life-sciences-power\/\" title=\"Canada has the science. Does it have the strategy to be a life sciences power?\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1197\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/07\/announcement-3-1784646245-1.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    adMare Insights \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">07.21.2026<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Canada has the science. Does it have the strategy to be a life sciences power?<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-2409 post type-post status-publish format-standard has-post-thumbnail hentry category-admare-insights\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/the-future-of-bioinnovation-what-canada-must-do-now-to-lead\/\" title=\"The Future of BioInnovation: What Canada Must Do Now to Lead\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1498\" height=\"854\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/06\/Screenshot-2026-07-14-at-11.25.48-AM.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    adMare Insights \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">06.26.2026<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">The Future of BioInnovation: What Canada Must Do Now to Lead<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-2402 post type-post status-publish format-standard has-post-thumbnail hentry category-admare-news\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/admare-executive-institute-opens-applications-for-ninth-cohort\/\" title=\"adMare Executive Institute Opens Applications for Ninth Cohort\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1199\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/07\/announcement-2-1781557808.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    adMare News \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">06.16.2026<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">adMare Executive Institute Opens Applications for Ninth Cohort<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-2396 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/voxcell-bioinnovation-and-admare-bioinnovations-partner-to-advance-novel-antibody-therapies-in-a-human-relevant-vascularized-tissue-platform\/\" title=\"VoxCell BioInnovation and adMare BioInnovations Partner to Advance Novel Antibody Therapies in a Human-Relevant Vascularized Tissue Platform\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"799\" height=\"418\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/07\/1778682975191-1781646728-1.jpg\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">05.13.2026<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">VoxCell BioInnovation and adMare BioInnovations Partner to Advance Novel Antibody Therapies in a Human-Relevant Vascularized Tissue Platform<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1612 post type-post status-publish format-standard has-post-thumbnail hentry category-admare-news category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/abbvie-and-admare-bioinnovations-announce-rime-therapeutics-as-abbvie-biotech-innovators-award-recipient-in-quebec\/\" title=\"AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1199\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/announcement-1777575879.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    adMare News, Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">04.30.2026<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">AbbVie and adMare BioInnovations Announce RIME Therapeutics as AbbVie Biotech Innovators Award Recipient in Quebec<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1616 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/epitopea-announces-approval-of-ovact-clinical-trial-application-for-cryptivax-1001-in-advanced-high-grade-serous-ovarian-cancer\/\" title=\"Epitopea Announces Approval of OVACT Clinical Trial Application for CryptiVax-1001 in Advanced High-Grade Serous Ovarian Cancer\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/epitopeanews-en-1739975092.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">04.23.2026<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Epitopea Announces Approval of OVACT Clinical Trial Application for CryptiVax-1001 in Advanced High-Grade Serous Ovarian Cancer<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1619 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/thryv-therapeutics-commences-patient-dosing-in-wave-ii-clinical-study-for-long-qt-syndrome-and-receives-fda-fast-track-designation-for-thrv-1268\/\" title=\"Thryv Therapeutics Commences Patient Dosing in Wave II Clinical Study for Long QT Syndrome and Receives FDA Fast Track Designation for THRV-1268\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1199\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/thryv-therapeutics-eng-1-1758136916-1.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">04.22.2026<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Thryv Therapeutics Commences Patient Dosing in Wave II Clinical Study for Long QT Syndrome and Receives FDA Fast Track Designation for THRV-1268<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1490 post type-post status-publish format-standard has-post-thumbnail hentry category-admare-news\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-officially-opens-m4-innovation-centre-in-vancouver-to-support-the-growth-of-life-sciences-companies-in-canada\/\" title=\"adMare BioInnovations Officially Opens M4 Innovation Centre in Vancouver to Support the Growth of Life Sciences Companies in Canada\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1198\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/04\/annoucement_m4_eng-1776364058.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    adMare News \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">04.16.2026<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">adMare BioInnovations Officially Opens M4 Innovation Centre in Vancouver to Support the Growth of Life Sciences Companies in Canada<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1622 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/kainova-therapeutics-expands-phase-i-ii-trial-of-dt-7012-a-treg-depleting-anti-ccr8-antibody-with-first-patient-dosed-in-europe\/\" title=\"Kainova Therapeutics Expands Phase I \/ II Trial of DT-7012, a Treg-depleting Anti-CCR8 Antibody, with First Patient Dosed in Europe\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1198\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/zymeworks-en-1768231861.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">04.09.2026<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Kainova Therapeutics Expands Phase I \/ II Trial of DT-7012, a Treg-depleting Anti-CCR8 Antibody, with First Patient Dosed in Europe<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1625 post type-post status-publish format-standard has-post-thumbnail hentry category-admare-news\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-leadership-announcement\/\" title=\"adMare BioInnovations Leadership Announcement\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1198\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/en-leadership-1-1775049276.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    adMare News \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">03.31.2026<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">adMare BioInnovations Leadership Announcement<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1628 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/grant-to-develop-a-machine-learning-platform-to-accelerate-the-development-of-the-companys-dualase-based-therapeutics\/\" title=\"Grant to Develop a Machine Learning Platform to Accelerate the Development of the Company&#8217;s Dualase\u00ae-based Therapeutics\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/specificen-1749651081.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">03.19.2026<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Grant to Develop a Machine Learning Platform to Accelerate the Development of the Company&#8217;s Dualase\u00ae-based Therapeutics<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1631 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/kainova-therapeutics-announces-positive-phase-i-results-for-dt-9081-an-oral-ep4-receptor-antagonist-in-advanced-solid-tumors\/\" title=\"Kainova Therapeutics Announces Positive Phase I Results for DT-9081, an Oral EP4 Receptor Antagonist, in Advanced Solid Tumors\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1198\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/zymeworks-en-1768231861-1.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">03.10.2026<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Kainova Therapeutics Announces Positive Phase I Results for DT-9081, an Oral EP4 Receptor Antagonist, in Advanced Solid Tumors<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1634 post type-post status-publish format-standard has-post-thumbnail hentry category-admare-news category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/new-canadian-biotech-26therapeutics-inc-targets-root-cause-of-dry-eye-disease-with-first-in-class-therapy\/\" title=\"New Canadian Biotech 26therapeutics Inc. Targets Root Cause of Dry Eye Disease with First-in-Class Therapy\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1198\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/26tx_eng-1772591710.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    adMare News, Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">03.04.2026<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">New Canadian Biotech 26therapeutics Inc. Targets Root Cause of Dry Eye Disease with First-in-Class Therapy<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1637 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/kainova-therapeutics-secures-32m-cad-to-accelerate-development-of-immuno-oncology-and-inflammation-therapies\/\" title=\"Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1198\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/zymeworks-en-1768231861-1.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">02.10.2026<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1639 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/ocythera-secures-seed-financing-from-admare-bioinnovations-and-fonds-impulsion-to-advance-therapies-for-rare-bone-diseases\/\" title=\"Ocythera Secures Seed Financing from adMare BioInnovations and Fonds Impulsion to Advance Therapies for Rare Bone Diseases\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1198\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/ocythera_eng-1769531742.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">01.27.2026<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Ocythera Secures Seed Financing from adMare BioInnovations and Fonds Impulsion to Advance Therapies for Rare Bone Diseases<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1642 post type-post status-publish format-standard has-post-thumbnail hentry category-admare-news category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-launches-ocythera-a-new-canadian-life-sciences-company-advancing-therapies-for-rare-bone-diseases\/\" title=\"adMare BioInnovations Launches Ocythera: A New Canadian Life Sciences Company Advancing Therapies for Rare Bone Diseases\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1198\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/ocythera_eng-1768345717.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    adMare News, Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">01.15.2026<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">adMare BioInnovations Launches Ocythera: A New Canadian Life Sciences Company Advancing Therapies for Rare Bone Diseases<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1645 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/thryv-therapeutics-launches-pivotal-wave-ii-phase-2-3-study-in-long-qt-syndrome-type-2\/\" title=\"Thryv Therapeutics Launches Pivotal Wave II Phase 2\/3 Study in Long QT Syndrome Type 2\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1199\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/thryv-therapeutics-eng-1-1758136916-1.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">01.13.2026<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Thryv Therapeutics Launches Pivotal Wave II Phase 2\/3 Study in Long QT Syndrome Type 2<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1647 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/domain-therapeutics-rebrands-as-kainova-therapeutics-advancing-its-clinical-pipeline-of-gpcr-modulating-therapies\/\" title=\"Domain Therapeutics Rebrands as Kainova Therapeutics Advancing Its Clinical Pipeline of GPCR-Modulating Therapies\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1198\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/zymeworks-en-1768231861-1.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">01.12.2026<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Domain Therapeutics Rebrands as Kainova Therapeutics Advancing Its Clinical Pipeline of GPCR-Modulating Therapies<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1649 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/find-therapeutics-announces-series-a-extension-financing-and-appointment-of-dr-thierry-abribat-as-executive-chairman-of-the-board\/\" title=\"Find Therapeutics Announces Series A Extension Financing and Appointment of Dr. Thierry Abribat as Executive Chairman of the Board\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/findnews-en-1726494130.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">01.09.2026<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Find Therapeutics Announces Series A Extension Financing and Appointment of Dr. Thierry Abribat as Executive Chairman of the Board<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1652 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/thryv-therapeutics-announces-positive-phase-1-results-of-thrv-1268-in-obese-participants\/\" title=\"Thryv Therapeutics Announces Positive Phase 1 Results of THRV-1268 in Obese Participants\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1199\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/thryv-therapeutics-eng-1-1758136916-1.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">12.17.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Thryv Therapeutics Announces Positive Phase 1 Results of THRV-1268 in Obese Participants<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1654 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/specific-biologics-welcomes-accomplished-biotechnology-leader-dr-richard-glickman-to-its-board-of-directors\/\" title=\"Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/specificen-1749651081.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">12.16.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1656 post type-post status-publish format-standard has-post-thumbnail hentry category-admare-news\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-launches-cohort-viii-of-the-executive-institute-to-strengthen-leadership-driving-canadian-life-sciences-company-growth\/\" title=\"adMare BioInnovations Launches Cohort VIII of the Executive Institute to Strengthen Leadership Driving Canadian Life Sciences Company Growth\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/ei_cohort-viii_eng-1765477906.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    adMare News \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">12.11.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">adMare BioInnovations Launches Cohort VIII of the Executive Institute to Strengthen Leadership Driving Canadian Life Sciences Company Growth<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1659 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/thryv-therapeutics-strengthens-senior-leadership-team-with-appointment-of-matt-killeen-phd-as-chief-business-officer\/\" title=\"Thryv Therapeutics Strengthens Senior Leadership Team with Appointment of Matt Killeen, PhD, as Chief Business Officer\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1199\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/thryv-therapeutics-eng-1-1758136916-1.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">12.03.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Thryv Therapeutics Strengthens Senior Leadership Team with Appointment of Matt Killeen, PhD, as Chief Business Officer<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1661 post type-post status-publish format-standard has-post-thumbnail hentry category-admare-news\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/castl-expands-national-biomanufacturing-training-with-bioinnovation-scientist-bis-program\/\" title=\"CASTL Expands National Biomanufacturing Training with BioInnovation Scientist (BIS) Program\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1840\" height=\"1021\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/bis-image-1763743515-1764303858.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" srcset=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/bis-image-1763743515-1764303858.png 1840w, https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/bis-image-1763743515-1764303858-1536x852.png 1536w\" sizes=\"auto, (max-width: 1840px) 100vw, 1840px\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    adMare News \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">11.27.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">CASTL Expands National Biomanufacturing Training with BioInnovation Scientist (BIS) Program<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1664 post type-post status-publish format-standard has-post-thumbnail hentry category-admare-news\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/abbvie-and-admare-bioinnovations-foster-life-sciences-innovation-with-the-launch-of-the-abbvie-biotech-innovators-award-in-quebec\/\" title=\"AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/announcement-1763994522.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    adMare News \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">11.25.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">AbbVie and adMare BioInnovations Foster Life Sciences Innovation with the Launch of the AbbVie Biotech Innovators Award in Quebec<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1669 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/pathway-to-cures-invests-in-seragene-therapeutics\/\" title=\"Pathway to Cures Invests in SeraGene Therapeutics\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1198\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/accelmay2024en-1763649271.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">11.20.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Pathway to Cures Invests in SeraGene Therapeutics<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1667 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/amy-rudolph-phd-joins-thryv-therapeutics-board-of-directors-to-support-portfolio-progression-into-heart-failure\/\" title=\"Amy Rudolph, PhD, Joins Thryv Therapeutics\u2019 Board of Directors to Support Portfolio Progression into Heart Failure\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1199\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/thryv-therapeutics-eng-1-1758136916-1.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">11.19.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Amy Rudolph, PhD, Joins Thryv Therapeutics\u2019 Board of Directors to Support Portfolio Progression into Heart Failure<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1672 post type-post status-publish format-standard has-post-thumbnail hentry category-admare-insights\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/with-the-u-s-on-uncertain-footing-quebec-must-stand-strong-in-life-sciences\/\" title=\"With the U.S. on uncertain footing, Quebec must stand strong in life sciences\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"923\" height=\"616\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/d2d689d995f73d6583f6ef266bf80233-1762383953.webp\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    adMare Insights \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">11.05.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">With the U.S. on uncertain footing, Quebec must stand strong in life sciences<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1675 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/domain-therapeutics-doses-first-patients-in-phase-i-ii-trial-of-dt-7012-targeting-ccr8-in-solid-tumors\/\" title=\"Domain Therapeutics Doses First Patients in Phase I\/II Trial of DT-7012 Targeting CCR8 in Solid Tumors\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/domain-tx-en-1686256044.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">10.28.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Domain Therapeutics Doses First Patients in Phase I\/II Trial of DT-7012 Targeting CCR8 in Solid Tumors<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1678 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/epitopea-strengthens-scientific-advisory-board-with-appointment-of-four-world-renowned-experts-in-cancer-immunology-and-immunotherapy\/\" title=\"Epitopea Strengthens Scientific Advisory Board with Appointment of Four World Renowned Experts in Cancer Immunology and Immunotherapy\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/epitopeanews-en-1739975092.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">09.18.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Epitopea Strengthens Scientific Advisory Board with Appointment of Four World Renowned Experts in Cancer Immunology and Immunotherapy<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1682 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/abdera-therapeutics-presents-initial-phase-1-clinical-data-on-abd-147-a-next-generation-dll3-targeting-radiopharmaceutical-therapy-at-iaslc-2025-world-conference-on-lung-cancer\/\" title=\"Abdera Therapeutics Presents Initial Phase 1 Clinical Data on ABD-147, a Next-generation DLL3-targeting Radiopharmaceutical Therapy, at IASLC 2025 World Conference on Lung Cancer\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1199\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/abdera-therapeutics-en-1757440675.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">09.17.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Abdera Therapeutics Presents Initial Phase 1 Clinical Data on ABD-147, a Next-generation DLL3-targeting Radiopharmaceutical Therapy, at IASLC 2025 World Conference on Lung Cancer<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1680 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/thryv-therapeutics-announces-fda-ind-clearance-of-thrv-1268-for-long-qt-syndrome\/\" title=\"Thryv Therapeutics Announces FDA IND Clearance of THRV-1268 for Long QT Syndrome\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1199\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/thryv-therapeutics-eng-1-1758136916-1.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">09.17.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Thryv Therapeutics Announces FDA IND Clearance of THRV-1268 for Long QT Syndrome<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1685 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/thryv-therapeutics-receives-fda-ind-clearance-of-thrv-1268-for-heart-failure-and-atrial-fibrillation-and-presents-sgk1-inhibition-results-combined-with-jardiance-in-pressure-overload-model-at-esc-2025\/\" title=\"Thryv Therapeutics Receives FDA IND Clearance of THRV-1268 for Heart Failure and Atrial Fibrillation and Presents SGK1 Inhibition Results Combined with Jardiance in Pressure Overload Model at ESC 2025\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1199\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/thryv-therapeutics-eng-1-1758136916-1.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">09.08.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Thryv Therapeutics Receives FDA IND Clearance of THRV-1268 for Heart Failure and Atrial Fibrillation and Presents SGK1 Inhibition Results Combined with Jardiance in Pressure Overload Model at ESC 2025<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1687 post type-post status-publish format-standard has-post-thumbnail hentry category-admare-news\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/admare-executive-institute-opens-applications-for-eighth-cohort\/\" title=\"adMare Executive Institute Opens Applications for Eighth Cohort\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1199\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/exec-institute-cohort-viii-announcement-1753713280.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    adMare News \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">07.28.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">adMare Executive Institute Opens Applications for Eighth Cohort<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1690 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/epitopea-expands-its-clinical-development-and-research-capabilities-as-it-accelerates-to-the-clinic\/\" title=\"Epitopea Expands its Clinical Development and Research Capabilities as it Accelerates to the Clinic\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/epitopeanews-en-1739975092.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">07.10.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Epitopea Expands its Clinical Development and Research Capabilities as it Accelerates to the Clinic<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1692 post type-post status-publish format-standard has-post-thumbnail hentry category-admare-insights\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/new-admare-institute-report-examines-capital-flows-in-canadian-life-sciences-and-the-urgent-need-to-capture-domestic-economic-value\/\" title=\"New adMare Institute Report Examines Capital Flows in Canadian Life Sciences and the Urgent Need to Capture Domestic Economic Value\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"719\" height=\"426\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/es-admare-websitetitlecard_01-1752065352.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    adMare Insights \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">07.09.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">New adMare Institute Report Examines Capital Flows in Canadian Life Sciences and the Urgent Need to Capture Domestic Economic Value<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1695 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/9bio-therapeutics-selected-by-merck-global-health-innovation-fund-and-cqdm-for-strategic-investment-and-acceleration-program\/\" title=\"9Bio Therapeutics selected by Merck Global Health Innovation Fund and CQDM for strategic investment and acceleration program\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2025\/06\/accelmay2024en-2-1740158243.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">06.23.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">9Bio Therapeutics selected by Merck Global Health Innovation Fund and CQDM for strategic investment and acceleration program<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1698 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/specific-biologics-welcomes-paul-j-hastings-as-chair-of-the-board-of-directors\/\" title=\"Specific Biologics Welcomes Paul J. Hastings as Chair of the Board of Directors\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/specificen-1749651081.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">06.11.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Specific Biologics Welcomes Paul J. Hastings as Chair of the Board of Directors<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1702 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/1-8m-quebec-backed-collaboration-between-9bio-and-vega-advances-precision-oncology-innovation\/\" title=\"$1.8M Quebec-backed collaboration between 9Bio and Vega advances precision oncology innovation\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2025\/06\/accelmay2024en-2-1740158243.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">05.14.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">$1.8M Quebec-backed collaboration between 9Bio and Vega advances precision oncology innovation<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1704 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/zucara-therapeutics-announces-second-and-final-closing-of-us25-million-series-b-financing\/\" title=\"Zucara Therapeutics Announces Second and Final Closing of US$25 Million Series B Financing\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1199\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/zucaranews-en-1746106365.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">05.01.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Zucara Therapeutics Announces Second and Final Closing of US$25 Million Series B Financing<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1707 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/two-key-experts-joining-find-therapeutics-to-accelerate-the-development-of-ftx-101\/\" title=\"Two key experts joining Find Therapeutics to accelerate the development of FTX-101\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/findnews-en-1726494130.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">04.10.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Two key experts joining Find Therapeutics to accelerate the development of FTX-101<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1709 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/9bio-therapeutics-secures-strategic-funding-to-advance-its-oncology-pipeline\/\" title=\"9Bio Therapeutics secures strategic funding to advance its oncology pipeline\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2025\/06\/accelmay2024en-2-1740158243.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">02.21.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">9Bio Therapeutics secures strategic funding to advance its oncology pipeline<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1711 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/epitopea-announces-license-and-research-collaboration-agreement-with-msd-to-identify-cryptigentm-tumor-specific-antigens\/\" title=\"Epitopea Announces License and Research Collaboration Agreement with MSD to Identify CryptigenTM Tumor-Specific Antigens\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/epitopeanews-en-1739975092.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">02.19.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Epitopea Announces License and Research Collaboration Agreement with MSD to Identify CryptigenTM Tumor-Specific Antigens<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1700 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/epitopea-announces-nature-cancer-paper-on-novel-immunotherapy-targets-in-melanoma-and-nsclc\/\" title=\"Epitopea Announces Nature Cancer Paper on Novel Immunotherapy Targets in Melanoma and NSCLC\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/epitopeanews-en-1739975092.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">02.19.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Epitopea Announces Nature Cancer Paper on Novel Immunotherapy Targets in Melanoma and NSCLC<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1713 post type-post status-publish format-standard has-post-thumbnail hentry category-admare-news\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/government-of-canada-invests-6-million-to-drive-growth-in-b-c-s-life-sciences-sector\/\" title=\"Government of Canada invests $6 million to drive growth in B.C.\u2019s life sciences sector\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1198\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/announcement-1738953626.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    adMare News \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">02.07.2025<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Government of Canada invests $6 million to drive growth in B.C.\u2019s life sciences sector<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1719 post type-post status-publish format-standard has-post-thumbnail hentry category-admare-news\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-welcomes-cohort-vii-of-the-executive-institute-strengthening-canadas-life-sciences-leadership\/\" title=\"adMare BioInnovations Welcomes Cohort VII of the Executive Institute, Strengthening Canada\u2019s Life Sciences Leadership\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1198\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/announcement-3-1733349540.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    adMare News \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">12.04.2024<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">adMare BioInnovations Welcomes Cohort VII of the Executive Institute, Strengthening Canada\u2019s Life Sciences Leadership<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1722 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/kisoji-biotechnology-raises-41-million-to-advance-lead-program-into-the-clinic-and-deploy-ai-tools-into-key-pipeline-indications\/\" title=\"KisoJi Biotechnology Raises $41 Million to Advance Lead Program Into the Clinic and Deploy AI Tools Into Key Pipeline Indications\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1198\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/kisojinews-en-1733150601.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">12.02.2024<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">KisoJi Biotechnology Raises $41 Million to Advance Lead Program Into the Clinic and Deploy AI Tools Into Key Pipeline Indications<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1725 post type-post status-publish format-standard has-post-thumbnail hentry category-admare-news category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-spins-out-analytical-services-to-paraza-pharma-catalyzing-growth-and-innovation\/\" title=\"adMare BioInnovations Spins Out Analytical Services to Paraza Pharma, Catalyzing Growth and Innovation\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1198\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/paraza-eng-1732803730.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    adMare News, Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">11.28.2024<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">adMare BioInnovations Spins Out Analytical Services to Paraza Pharma, Catalyzing Growth and Innovation<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1728 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/fda-grants-u-s-approval-of-ziihera-zanidatamab-hrii-for-the-treatment-of-adults-with-previously-treated-unresectable-or-metastatic-her2-positive-ihc-3-biliary-tract-cancer-btc\/\" title=\"FDA Grants U.S. Approval of Ziihera\u00ae (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/zymeworks-en-1729863234.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">11.21.2024<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">FDA Grants U.S. Approval of Ziihera\u00ae (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1731 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/thryv-therapeutics-announces-completion-of-phase-1-dosing-of-its-second-novel-sgk1-inhibitor-thrv-1268-future-studies-in-heart-failure-and-atrial-fibrillation-to-commence-in-2025\/\" title=\"Thryv Therapeutics Announces Completion of Phase 1 Dosing of its Second Novel SGK1 Inhibitor THRV-1268 &#8211; Future Studies in Heart Failure and Atrial Fibrillation to Commence in 2025\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1199\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/thryv-therapeutics-eng-1-1758136916-1.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">11.15.2024<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Thryv Therapeutics Announces Completion of Phase 1 Dosing of its Second Novel SGK1 Inhibitor THRV-1268 &#8211; Future Studies in Heart Failure and Atrial Fibrillation to Commence in 2025<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1733 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/zucara-therapeutics-announces-strategic-investment-from-sanofi-as-part-of-us20-million-series-b-financing\/\" title=\"Zucara Therapeutics Announces Strategic Investment from Sanofi as Part of US$20 Million Series B Financing\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1199\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/zucaranews-en-1746106365.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">11.12.2024<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Zucara Therapeutics Announces Strategic Investment from Sanofi as Part of US$20 Million Series B Financing<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1735 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/zymeworks-announces-first-patient-dosed-in-phase-1-clinical-trial-evaluating-zw171-in-advanced-mesothelin-expressing-cancers\/\" title=\"Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/zymeworks-en-1729863234.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">10.25.2024<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesothelin-Expressing Cancers<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1739 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/epitopea-closes-usd-31-million-pre-series-a-financing\/\" title=\"Epitopea Closes USD $31 million Pre-Series A Financing\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/epitopeanews-en-1739975092.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">10.24.2024<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Epitopea Closes USD $31 million Pre-Series A Financing<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1737 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/cancer-research-uk-and-kisoji-biotechnology-collaborate-to-advance-the-first-naked-antibody-against-trop2-into-the-clinic\/\" title=\"Cancer Research UK and KisoJi Biotechnology Collaborate to Advance the First Naked Antibody Against TROP2 Into the Clinic\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1198\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/kisojinews-en-1733150601.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">10.24.2024<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Cancer Research UK and KisoJi Biotechnology Collaborate to Advance the First Naked Antibody Against TROP2 Into the Clinic<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1741 post type-post status-publish format-standard has-post-thumbnail hentry category-admare-news\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-celebrates-successes-of-admare-tx-accelerator-companies-concludes-ontario-partnership-with-mars\/\" title=\"adMare BioInnovations Celebrates Successes of adMare Tx Accelerator Companies, Concludes Ontario Partnership with MaRS\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1198\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/accelannouncement-coming-soon-1729601312.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    adMare News \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">10.22.2024<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">adMare BioInnovations Celebrates Successes of adMare Tx Accelerator Companies, Concludes Ontario Partnership with MaRS<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1744 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/find-therapeutics-announces-first-subject-dosed-in-phase-1-clinical-study-of-ftx-101\/\" title=\"Find Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of FTX-101\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/findnews-en-1726494130.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">10.21.2024<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Find Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of FTX-101<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1746 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/thryv-therapeutics-receives-positive-top-line-results-from-wave-i-part-2-clinical-study-in-long-qt-syndrome-type-2-and-type-3-patients\/\" title=\"Thryv Therapeutics Receives Positive Top-Line Results from Wave I Part 2 Clinical Study in Long QT Syndrome Type 2 and Type 3 Patients\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1199\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/thryv-therapeutics-eng-1-1758136916-1.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">10.15.2024<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Thryv Therapeutics Receives Positive Top-Line Results from Wave I Part 2 Clinical Study in Long QT Syndrome Type 2 and Type 3 Patients<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1748 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/thryv-therapeutics-granted-fda-orphan-drug-designation-for-lqt-1213-in-long-qt-syndrome-treatment\/\" title=\"Thryv Therapeutics Granted FDA Orphan Drug Designation for LQT-1213 in Long QT Syndrome Treatment\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1199\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/thryv-therapeutics-eng-1-1758136916-1.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">10.02.2024<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">Thryv Therapeutics Granted FDA Orphan Drug Designation for LQT-1213 in Long QT Syndrome Treatment<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1750 post type-post status-publish format-standard has-post-thumbnail hentry category-admare-news\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/admare-bioinnovations-appoints-marc-riviere-to-its-board-of-directors\/\" title=\"adMare BioInnovations Appoints Marc Rivi\u00e8re to its Board of Directors\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1198\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/marc-riviere-en-1726840265.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    adMare News \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">09.20.2024<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">adMare BioInnovations Appoints Marc Rivi\u00e8re to its Board of Directors<\/p>\n    <\/a>\n\n<\/div><\/li><li class=\"wp-block-post post-1753 post type-post status-publish format-standard has-post-thumbnail hentry category-portfolio-companies\"><div class=\"wp-block-group post-item\">\n    <a class=\"news-linked-card\" href=\"https:\/\/admarebio.com\/news-events\/news-insights\/nanovation-therapeutics-announces-multi-target-partnership-with-novo-nordisk-to-develop-genetic-medicines-targeting-cardiometabolic-and-rare-diseases\/\" title=\"NanoVation Therapeutics Announces Multi-Target Partnership with Novo Nordisk to Develop Genetic Medicines Targeting Cardiometabolic and Rare Diseases\" style=\"text-decoration: none;\">\n                    <figure class=\"wp-block-image\">\n                <img loading=\"lazy\" decoding=\"async\" width=\"1200\" height=\"628\" src=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/05\/zucaranews-en-1726667805.png\" class=\"attachment-full size-full wp-post-image\" alt=\"\" \/>            <\/figure>\n                <div class=\"wp-block-group\" style=\"display:flex;justify-content: space-between;\">\n            <p class=\"has-xsmall-font-size has-block-color\" style=\"margin: 0\">\n                                    Portfolio Companies \n                            <\/p>\n            <p class=\"has-xsmall-font-size has-black-color\" style=\"margin: 0\">09.18.2024<\/p>\n        <\/div>\n        <p class=\"post-title has-small-font-size has-black-color\" style=\"font-weight: 700;margin-top:var(--wp--preset--spacing--20)\">NanoVation Therapeutics Announces Multi-Target Partnership with Novo Nordisk to Develop Genetic Medicines Targeting Cardiometabolic and Rare Diseases<\/p>\n    <\/a>\n\n<\/div><\/li>\n\n<div class=\"is-layout-flex pagination-links has-large-font-size\" style=\"flex-wrap: nowrap; justify-content: center; grid-column: 1\/-1; padding-top: var(--wp--preset--spacing--50); margin-top: 0;\">\n\t\t<a class=\"previous disabled\" data-page=\"1\" href=\"\" aria-label=\"Previous page\" title=\"Previous page\">Previous<\/a>\n\n\t\t\t<a class=\"page-number active\" data-page=\"1\" href=\"\/en\/wp-json\/wp\/v2\/pages\/32?_paged=1\" aria-label=\"Page 1\" title=\"Page 1\">1<\/a>\n\t\t\t<a class=\"page-number \" data-page=\"2\" href=\"\/en\/wp-json\/wp\/v2\/pages\/32?_paged=2\" aria-label=\"Page 2\" title=\"Page 2\">2<\/a>\n\t\n\t\t<a class=\"next \" data-page=\"2\" href=\"\/en\/wp-json\/wp\/v2\/pages\/32?_paged=2\" aria-label=\"Next page\" title=\"Next page\">Next<\/a>\n<\/div>\n\t\t<\/ul>\n\t<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":30,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"light-footer","meta":{"footnotes":""},"class_list":["post-32","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News &amp; Insights | adMare<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News &amp; Insights | adMare\" \/>\n<meta property=\"og:url\" content=\"https:\/\/admarebio.com\/en\/news-events\/news-insights\/\" \/>\n<meta property=\"og:site_name\" content=\"adMare\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-24T14:48:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/03\/Homepage-Gradient-flip.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2561\" \/>\n\t<meta property=\"og:image:height\" content=\"1708\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/news-events\\\/news-insights\\\/\",\"url\":\"https:\\\/\\\/admarebio.com\\\/en\\\/news-events\\\/news-insights\\\/\",\"name\":\"News & Insights | adMare\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/news-events\\\/news-insights\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/news-events\\\/news-insights\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Homepage-Gradient-flip.png\",\"datePublished\":\"2026-02-02T14:51:01+00:00\",\"dateModified\":\"2026-03-24T14:48:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/news-events\\\/news-insights\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/admarebio.com\\\/en\\\/news-events\\\/news-insights\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/news-events\\\/news-insights\\\/#primaryimage\",\"url\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Homepage-Gradient-flip.png\",\"contentUrl\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Homepage-Gradient-flip.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/news-events\\\/news-insights\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/admarebio.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News &#038; Events\",\"item\":\"https:\\\/\\\/admarebio.com\\\/en\\\/news-events\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News &#038; Insights\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/admarebio.com\\\/en\\\/\",\"name\":\"adMare\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/admarebio.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#organization\",\"name\":\"adMare\",\"url\":\"https:\\\/\\\/admarebio.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Logo-light.svg\",\"contentUrl\":\"https:\\\/\\\/admarebio.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Logo-light.svg\",\"width\":915,\"height\":337,\"caption\":\"adMare\"},\"image\":{\"@id\":\"https:\\\/\\\/admarebio.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"News & Insights | adMare","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"News & Insights | adMare","og_url":"https:\/\/admarebio.com\/en\/news-events\/news-insights\/","og_site_name":"adMare","article_modified_time":"2026-03-24T14:48:25+00:00","og_image":[{"width":2561,"height":1708,"url":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/03\/Homepage-Gradient-flip.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/admarebio.com\/en\/news-events\/news-insights\/","url":"https:\/\/admarebio.com\/en\/news-events\/news-insights\/","name":"News & Insights | adMare","isPartOf":{"@id":"https:\/\/admarebio.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/admarebio.com\/en\/news-events\/news-insights\/#primaryimage"},"image":{"@id":"https:\/\/admarebio.com\/en\/news-events\/news-insights\/#primaryimage"},"thumbnailUrl":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/03\/Homepage-Gradient-flip.png","datePublished":"2026-02-02T14:51:01+00:00","dateModified":"2026-03-24T14:48:25+00:00","breadcrumb":{"@id":"https:\/\/admarebio.com\/en\/news-events\/news-insights\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/admarebio.com\/en\/news-events\/news-insights\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/admarebio.com\/en\/news-events\/news-insights\/#primaryimage","url":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/03\/Homepage-Gradient-flip.png","contentUrl":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/03\/Homepage-Gradient-flip.png"},{"@type":"BreadcrumbList","@id":"https:\/\/admarebio.com\/en\/news-events\/news-insights\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/admarebio.com\/en\/"},{"@type":"ListItem","position":2,"name":"News &#038; Events","item":"https:\/\/admarebio.com\/en\/news-events\/"},{"@type":"ListItem","position":3,"name":"News &#038; Insights"}]},{"@type":"WebSite","@id":"https:\/\/admarebio.com\/en\/#website","url":"https:\/\/admarebio.com\/en\/","name":"adMare","description":"","publisher":{"@id":"https:\/\/admarebio.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/admarebio.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/admarebio.com\/en\/#organization","name":"adMare","url":"https:\/\/admarebio.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/admarebio.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/03\/Logo-light.svg","contentUrl":"https:\/\/admarebio.com\/wp-content\/uploads\/2026\/03\/Logo-light.svg","width":915,"height":337,"caption":"adMare"},"image":{"@id":"https:\/\/admarebio.com\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/pages\/32","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/comments?post=32"}],"version-history":[{"count":13,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/pages\/32\/revisions"}],"predecessor-version":[{"id":960,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/pages\/32\/revisions\/960"}],"up":[{"embeddable":true,"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/pages\/30"}],"wp:attachment":[{"href":"https:\/\/admarebio.com\/en\/wp-json\/wp\/v2\/media?parent=32"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}